FR2376134A1 - Derives de 6-oxo-prostaglandines, leur procede de preparation et medicaments en contenant - Google Patents

Derives de 6-oxo-prostaglandines, leur procede de preparation et medicaments en contenant

Info

Publication number
FR2376134A1
FR2376134A1 FR7739685A FR7739685A FR2376134A1 FR 2376134 A1 FR2376134 A1 FR 2376134A1 FR 7739685 A FR7739685 A FR 7739685A FR 7739685 A FR7739685 A FR 7739685A FR 2376134 A1 FR2376134 A1 FR 2376134A1
Authority
FR
France
Prior art keywords
oxo
preparation process
products containing
medicinal products
prostaglandin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7739685A
Other languages
English (en)
Other versions
FR2376134B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/829,678 external-priority patent/US4124601A/en
Priority claimed from US05/829,679 external-priority patent/US4205178A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2376134A1 publication Critical patent/FR2376134A1/fr
Application granted granted Critical
Publication of FR2376134B1 publication Critical patent/FR2376134B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne de nouveaux dérivés et analogues de prostaglandine E (type PGE) portant un groupe 6-céto, par exemple l'ester méthylique de 6-céto-PGE1 de formule :
FR7739685A 1976-12-30 1977-12-29 Derives de 6-oxo-prostaglandines, leur procede de preparation et medicaments en contenant Granted FR2376134A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75567576A 1976-12-30 1976-12-30
US75567476A 1976-12-30 1976-12-30
US05/829,678 US4124601A (en) 1976-12-30 1977-09-02 Certain 5-halo-6,9α-epoxy-14-bromo(or chloro)-PGF1 compounds
US05/829,679 US4205178A (en) 1976-12-30 1977-09-02 6-Keto prostaglandin E-type compounds

Publications (2)

Publication Number Publication Date
FR2376134A1 true FR2376134A1 (fr) 1978-07-28
FR2376134B1 FR2376134B1 (fr) 1985-04-12

Family

ID=27505671

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7739685A Granted FR2376134A1 (fr) 1976-12-30 1977-12-29 Derives de 6-oxo-prostaglandines, leur procede de preparation et medicaments en contenant

Country Status (7)

Country Link
JP (1) JPS5811438B2 (fr)
AU (1) AU511711B2 (fr)
BE (1) BE862547A (fr)
DE (1) DE2753986C2 (fr)
FR (1) FR2376134A1 (fr)
GB (1) GB1565604A (fr)
NL (1) NL190600C (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362834A1 (fr) * 1976-02-04 1978-03-24 Upjohn Co Nouveaux derives 6-hemicetal ou 6-ceto de prostaglandine, leur procede de preparation et medicament les contenant
FR2401919A1 (fr) * 1977-07-28 1979-03-30 Upjohn Co Derives de prostaglandines
FR2413383A1 (fr) * 1977-12-30 1979-07-27 Erba Carlo Spa Derives de type 5,6-dihydro-prostacycline, leurs procedes de preparation et leurs applications therapeutiques
EP0008076A1 (fr) * 1978-08-04 1980-02-20 Hoechst Aktiengesellschaft Dérivés de prostaglandine de la série delta-2-11-désoxy-PGF2 ou PGE2, leur application et procédé pour leur préparation et procédé pour la préparation de médicaments
EP0019069A2 (fr) * 1979-04-06 1980-11-26 Hoechst Aktiengesellschaft Dérivés 6-céto- PGE1, procédé pour leur préparation et leur application thérapeutique; dérivés PGI1
EP0029527A2 (fr) * 1979-11-15 1981-06-03 Hoechst Aktiengesellschaft Dérivés 6-céto-PGA1 prostaglandine, procédé pour leur préparation et leur utilisation dans des médicaments et leurs intermédiaires
EP0100630A2 (fr) * 1982-07-22 1984-02-15 Ono Pharmaceutical Co., Ltd. Analogues de la prostaglandine E1
EP0232126A2 (fr) * 1986-01-30 1987-08-12 Ono Pharmaceutical Co., Ltd. Dérivés 6-céto-prostaglandine-E1
EP0276124A2 (fr) * 1987-01-19 1988-07-27 Sankyo Company Limited Dérivés de prostaglandine, leur préparation et leur application thérapeutique
WO1988007037A1 (fr) * 1987-03-13 1988-09-22 Schering Aktiengesellschaft Derives de 6-oxoprostaglandine, leur procede de production et leur application pharmaceutique

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner
JPS6022710B2 (ja) 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
DE2834248A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-pgf tief 2 und delta 2-pge tief 2 -reihe
DE3315356A1 (de) * 1982-04-30 1983-11-17 Ono Pharmaceutical Co. Ltd., Osaka Verwendung von prostaglandinanalogen
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
DE3704825A1 (de) * 1987-02-16 1988-08-25 Froelich Juergen Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung
JPH053100Y2 (fr) * 1988-04-28 1993-01-26
CA2382759A1 (fr) 1999-08-05 2001-02-15 Teijin Limited Ameliorant contre la neuropathie contenant des composes azotes en tant que principe actif

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362834A1 (fr) * 1976-02-04 1978-03-24 Upjohn Co Nouveaux derives 6-hemicetal ou 6-ceto de prostaglandine, leur procede de preparation et medicament les contenant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362834A1 (fr) * 1976-02-04 1978-03-24 Upjohn Co Nouveaux derives 6-hemicetal ou 6-ceto de prostaglandine, leur procede de preparation et medicament les contenant

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362834A1 (fr) * 1976-02-04 1978-03-24 Upjohn Co Nouveaux derives 6-hemicetal ou 6-ceto de prostaglandine, leur procede de preparation et medicament les contenant
FR2401919A1 (fr) * 1977-07-28 1979-03-30 Upjohn Co Derives de prostaglandines
FR2408588A1 (fr) * 1977-07-28 1979-06-08 Upjohn Co Derives de prostaglandines
FR2413383A1 (fr) * 1977-12-30 1979-07-27 Erba Carlo Spa Derives de type 5,6-dihydro-prostacycline, leurs procedes de preparation et leurs applications therapeutiques
EP0008076A1 (fr) * 1978-08-04 1980-02-20 Hoechst Aktiengesellschaft Dérivés de prostaglandine de la série delta-2-11-désoxy-PGF2 ou PGE2, leur application et procédé pour leur préparation et procédé pour la préparation de médicaments
EP0019069A2 (fr) * 1979-04-06 1980-11-26 Hoechst Aktiengesellschaft Dérivés 6-céto- PGE1, procédé pour leur préparation et leur application thérapeutique; dérivés PGI1
EP0019069A3 (en) * 1979-04-06 1981-01-14 Hoechst Aktiengesellschaft 6-keto pge1 compounds, their preparation and therapeutic application, pgi1 compounds
EP0029527A3 (fr) * 1979-11-15 1981-09-09 Hoechst Aktiengesellschaft Dérivés 6-céto-PGA1 prostaglandine, procédé pour leur préparation et leur utilisation dans des médicaments et leurs intermédiaires
EP0029527A2 (fr) * 1979-11-15 1981-06-03 Hoechst Aktiengesellschaft Dérivés 6-céto-PGA1 prostaglandine, procédé pour leur préparation et leur utilisation dans des médicaments et leurs intermédiaires
EP0100630A2 (fr) * 1982-07-22 1984-02-15 Ono Pharmaceutical Co., Ltd. Analogues de la prostaglandine E1
EP0100630A3 (en) * 1982-07-22 1984-08-08 Ono Pharmaceutical Co., Ltd. Prostaglandin e1 analogues
EP0232126A2 (fr) * 1986-01-30 1987-08-12 Ono Pharmaceutical Co., Ltd. Dérivés 6-céto-prostaglandine-E1
EP0232126A3 (en) * 1986-01-30 1987-11-25 Ono Pharmaceutical Co., Ltd. 6-keto-prostaglandin e1 derivatives
EP0276124A2 (fr) * 1987-01-19 1988-07-27 Sankyo Company Limited Dérivés de prostaglandine, leur préparation et leur application thérapeutique
EP0276124A3 (en) * 1987-01-19 1989-02-01 Sankyo Company Limited Prostaglandin derivatives, their preparation and their therapeutic use
WO1988007037A1 (fr) * 1987-03-13 1988-09-22 Schering Aktiengesellschaft Derives de 6-oxoprostaglandine, leur procede de production et leur application pharmaceutique
EP0284547A1 (fr) * 1987-03-13 1988-09-28 Schering Aktiengesellschaft Dérivés 6-oxo prostaglandine-E, leur préparation et médicaments les contenant

Also Published As

Publication number Publication date
NL7714172A (nl) 1978-07-04
AU3106777A (en) 1979-06-07
GB1565604A (en) 1980-04-23
FR2376134B1 (fr) 1985-04-12
DE2753986C2 (de) 1986-05-07
JPS5384942A (en) 1978-07-26
DE2753986A1 (de) 1978-07-06
JPS5811438B2 (ja) 1983-03-02
AU511711B2 (en) 1980-09-04
NL190600C (nl) 1994-05-16
NL190600B (nl) 1993-12-16
BE862547A (fr) 1978-06-30

Similar Documents

Publication Publication Date Title
FR2376134A1 (fr) Derives de 6-oxo-prostaglandines, leur procede de preparation et medicaments en contenant
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2416889A1 (fr) Derives esters de l'acide dihydro-1,4-pyridine-dicarboxylique-3,5, medicaments a base de ces derives et leur procede de production
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
FR2373513A1 (fr) Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
FR2403989A1 (fr) Nouveaux derives a-halogenomethyles d'amines utiles comme medicaments et procedes de leur preparation
LU80235A1 (fr) Analogues de la prostaglandine e1,compositions pharmaceutiques les contenant et procede de preparation
FR2361877A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur preparation et medicament les contenant
SE8600632D0 (sv) Novel pharmaceutical composition
FR2404626A1 (fr) Nouveaux derives a-halogenomethyles de l'acide g-aminobutyrique utiles comme medicaments et procedes de leur preparation
FR2361346A1 (fr) Dipeptides utiles comme medicaments
FR2404005A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
FR2429019A1 (fr) Medicaments contenant des esters de 1-b-d-arabinofuranosylcytosine-5'-phosphate
FR2364913A1 (fr) Nouveaux derives du benzopyranne utiles comme medicaments et leur procede de preparation
FR2365566A1 (fr) Nouveaux derives du thiophene utiles comme medicaments
FR2362841A1 (fr) Derives d'acides heterocyclyl-carboxyliques acyles utiles comme medicaments et procede pour leur preparation
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2384775A1 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament
FR2447375A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
FR2378757A1 (fr) Nor-o-heterocyclo-dehydro-13, 14 prostaglandines, leur procede de preparation et leur application comme medicaments
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
FR2373285A1 (fr) Nouveaux derives du coenzyme b 12, procede de preparation et application a titre de medicaments de ces nouveaux produits
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments